DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION
|
|
- Eustace McDaniel
- 5 years ago
- Views:
Transcription
1 Universitatea de Medicină şi Farmacie Grigore T. Popa Iaşi Comisia pentru asigurarea calităţii DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION 1. Information about the program UNIVERSITY: GRIGORE T. POPA UNIVERSITY OF MEDICINE AND PHARMACY OF 1.1. IAŞI 1.2. FACULTY: PHARMACY SCHOOL / DEPARTMENT: PHARMACEUTICAL SCIENCES II 1.3. SUBJECT: INDUSTRIAL PHARMACEUTICAL TECHNOLOGY 1.4. STUDY FIELD: PHARMACY 1.5. STUDY CYCLE: UNDERGRADUATE 1.6. STUDY PROGRAMME: IN ENGLISH 2. Subject data 2.1. SUBJECT: INDUSTRIAL PHARMACEUTICAL TECHNOLOGY 2.2. Module leader: Lecturer Carmen Gafitanu, PhD, Assoc. Prof. Gratiela Popa, PhD 2.3. Seminar leader: Lecturer Carmen Gafitanu, PhD, Assoc. Prof. Gratiela Popa, PhD, Assist. Andreea 2.4. Year of study Creteanu, PhD V 2.5. Semester in which is taught I 2.6. Evaluation type 3. Duration of the course (hours per semester) E Subject status Compulsory 3.1. Number of hours Number of Seminar / lab 3 / week hours / week 3.4.Total number of learning hours Total number of learning hours seminar / lab Distribution of activities in the course hours Study based on the manual, printed course, bibliography and notes 5 Additional research in the library, on specialized e-platforms and field study 5 Preparation for seminars, practical courses, portfolios and essays 10 Tutoring 10 Assessment - Other activities Number of hours of individual study Number of hours per semester Number of ECTS 4 4. Previous Knowledge (if applicable) 4.1. course related Pharmaceutical Propaedeutics, Physical Chemistry, Pharmaceutical Technology (3 rd and 4 th year of study, homogenous and heterogenous pharmaceutical dosage forms) skill related - notions about the homogenous and microheterogenous pharmaceutical dosage forms; - basic notions on formulation, preparation and quality control of pharmaceutical dosage forms.
2 5. Requirements (if applicable) 5.1. course conditions Video projector, work sheets, flip chart seminar / laboratory conditions Laboratory glassware, specific compounding tools, active drugs and excipients, laboratory-scale equipments for dosage forms preparation (pharmaceutical standard sieves, semi-automatic capsule filling apparatus, tablet press) ; devices for the quality control of pharmaceutical dosage forms. 6. Specific Skills Acquired Professional skills displayed by knowledge and skills Transversal skills (role skills, professional and personal skills) Design, formulation, industrial manufacture and packaging of medicines and dietary supplements. Storage, preservation and distribution of industrially manufactured medicines and dietary supplements. Quality control of medicines, dietary supplements, cosmetics and other health care products. Consultancy and expertise in the field industrial manufacture of medicines. Valorization of the acquired theoretical knowledge and adaptation to the requirements of the pharmaceutical industry. Communication skills (oral and in writing) specific to the pharmaceutical profession. Autonomy and resonsibility in taking professional decisions. 7. Course Objectives (confirmed by the grid of specific skills acquired) 7.1. General Objective Knowledge of the main important steps involved in the industrial design and manufacture of drugs: specific guidances for industry, preformulation and formulation aspects, industrial manufacture flow of dosage forms Specific Objectives Knowledge of solid oral dosage forms manufactured in the industry: medicated powders, capsules, granules, tablets, modified-release solid dosage forms. 8. Contents 8.1. Course Teaching methods Observations Manufacture steps of the industrial dosage forms Research and development: pilot scale manufacture and scale-up 2 hours steps; industrial manufacture of dosage forms. Definition, components and characteristics of the pharmaceutical industry, global concept of a pharmaceutical manufacturing plant. Essential elements in the quality of drug products: the four M concept: personnel (men), raw materials, machinery and methods. Industrial packaging, storage and shelf life of an industrial dosage form. Quality assurance and Good Manufacturing Practice in the pharmaceutical industry. Validation Solid dosage forms as heterogeneous disperse systems Dosage forms composed of individual particles -Powders: definition, advantages and limitations, types of powders, formulation goals. Pharmacopoeial standards. Factors influencing powder formulation. Powder properties. 8 hours
3 -Structural and dimensional properties: shape, particle size and diameter, size distribution of particles in a powder bed; density of powders. Electrical properties, superficial properties, mechanical properties, flow properties (rheology of powders). Technological properties influencing formulation; raw materials for powders: drugs, excipients. -Manufacture technology of powders: unit operations. Drying of solids; heat transfer methods: air circulation drying, conduction (hot surface) drying, radiation drying, microwave drying, drying of diluted solutions and suspensions, freeze-drying. Particle size reduction: methods and equipments for cutting and grinding; equipments for particle size reduction: mills. Powder sieving; pharmaceutical sieves: classification and characterization according to Pharmacopoeias; factors influencing powder sieving. Mixing of powders: mechanisms, mixing equipments. Technology of powders: clean rooms; manufacture steps. Quality assurance and control of powders. Encapsulated dosage forms -Definition, advantages, limitations, types of capsules. Starch capsules. Hard gelatin capsules: types, formulation, raw materials. Industrial manufacture: capsule wall, capsule content. Small scale filling of hard gelatin capsules (laboratory scale and pharmacy scale). -Industrial filling of hard gelatin capsules: equipments. Bioavailability, quality assurance and control of hard gelatin capsules. -Soft gelatin capsules. Formulation of content. Industrial manufacture: methods, equipments. Packaging and storage, quality assurance and control, bioavailability of soft gelatin capsules. Solid dosage forms made by aggregation and agglomeration of particles -Medicated gums. Soft lozenges. Hard candy lozenges. Medicated lollipops. Molded tablets. Medicated chocolates. -Granules: definition, advantages and limitations, formulation. Mechanisms of granulation. Raw materials. Industrial manufacture: dry granulation method. -Wet granulation methods: conventional wet granulation, high shear granulation, fluidized bed granulation, centrifugal bed granulation, spray drying granulation. Problems of granule drying: solvent migration. Packaging, storage, quality assurance and control. Bioavailability of granules. -Pellets definition, advantages, limitations. Formulation of pellets. Industrial methods: extrusion-spheronization, powder coating, centrifugal fluidization, liquid spray coating, spray congealing, meltextrusion. Quality assurance and control of pellets. Solid dosage forms made by agglomeration and compaction -Tablets definition, advantages, limitations; types of tablets, formulation. Desired characteristics for tabletting: compressibility, powder flow. Evaluation of compression behavior of powders and granules. -Physics of the compression process: factors influencing compaction and compression. Raw materials for tablet manufacture; excipients: fillers, binders, disintegrants, superdisintegrants, lubricants, glidants, 4 hours 5 hours 5 hours
4 other excipients. Manufacturing steps: compression cycle. -Tablet presses: types; tabletting steps through various methods: direct compression and indirect compression (dry granulation and wet granulation). Packaging and storage, quality assurance and control. Bioavailability of tablets. -Special formulations of fast release tablets: effervescent tablets, orally disintegrating tablets, sublingual tablets. -Tablets for other administration routes: vaginal, implantable tablets. Coated solid dosage forms -Definition, advantages, limitations, types of coating, formulation. Mechanisms of film formation, principles of coating. Coating technologies: equipments, methods. -Sugar coating, steps of industrial process. Film coating of tablets, press coarting, melt coating. Packaging and storage, quality assurance and control, bioavailability of coated dosage forms. Modified release dosage forms -Prolonged release dosage forms: formulation, manufacture. Sustained release, sequential release, controlled release dosage forms (tablets, capsules): reservoir systems, matrix systems, osmotic systems, gastroretentive systems, floating systems, bioadhesive systems. Targeted release systems. Video projections, (short Video projections, (short 2 hours 2 hours -Microcapsules, nanocapsules. Bibliography 1. Delivery Systems. 10th Edition. Allen LV, Ansel HC (editors). Lippincott, Williams & Wilkins, Popovici I, Lupuleasa D. Pharmaceutical Technology. 3 rd Edition, vol. I. Iasi: Polirom Publishing House, Popovici I, Lupuleasa D. Pharmaceutical Technology. Vol. III. Iasi: Polirom Publishing House, Leucuta S. Industrial Pharmaceutical Technology. Cluj-Napoca: Dacia Publishing House, Swarbrick J, Boylan JC. Encylopedia of Pharmaceutical Technology. New York: Ed. M. Dekker Inc., vol. I-IV, ***The Romanian Pharmacopoeia, 10 th Edition, 1993 and Supplements Bucharest: Medical Publishing House Seminar / Practical lessons Teaching Methods Observations 1. Solid dosage forms as macro-heterogeneous disperse systems Oral solid dosage forms. Pharmaceutical powders. Preparation, unit operations: drying, grinding/particle size reduction, sieving, mixing of powders 2. Powders -Pharmacopoeial standards: monographs in the Romanian Pharmacopoeia 10 th edition, European Pharmacopoeia 7 th edition; single active drug powders; packaging, storage and quality control. Compounding powders: bulk powders and divided powders; powders with different apparent densities, magistral preparations. -Multiple active drug powders (bulk powders): compounded and officinal preparations containing substances with water of hydration. Hygroscopic powders and eutectic mixture formation in powders. Industrial products: examples. -Powders with potent active drugs: controlled drugs (addictive, toxic drugs). Calculations of maximum therapeutic doses. Powders Performing the studied unit operations in laboratoryscale; Compounding the studied magistral examples; the studied topic. 3 hours 15 hours
5 containing coloured substances. -Powders containing lipophilic active drugs, volatile oils and substances. Industrial products: examples. -Topical powders- magistral and industrial examples. Quality control of powders, rheological behavior. 3. Capsules -Monographs in the Romanian Pharmacopoeia 10 th edition and Supplement Preparation of soft gelatin capsules by immersion method. Soft gelatin capsules containing lipophilic vitamins. Industrial examples. -Hard gelatin capsules laboratory scale filling of capsules using the Feton apparatus. Industrial examples of hard gelatin capsules. Quality control of capsules: in vitro disintegration test for soft and hard gelatin capsules. Laboratory-scale filling of hard gelatine capsules (using the Feton apparatus); 4. the studied topic. 5. Granules. Molded tablets. Lozenges -Granules Monographs in the Romanian Pharmacopoeia 10 th edition and Supplement Formulation, laboratory scale preparation of granules by conventional wet granulation method. Industrial and Laboratory-scale magistral examples of granules. preparation of granules; -Quality control of granules, in vitro disintegration test. Molded tablets, lozenges, medicated chocolates formulation, preparation methods, industrial examples. 6. Tablets -Monographs in the Romanian Pharmacopoeia 10 th edition, European Pharmacopoeia 7 th edition. Preparation of tablets by direct compression. Industrial examples. -Evaluation of compression and rheological properties of raw materials used in the preparation of tablets (via direct compression or with prior granulation): particle shape and size, flow speed, angle of repose, apparent volume, bulk density, tapped density of powders and granules. Hausner ratio, Carr index. -Preparation of tablets via indirect compression method: compression of granules obtained by wet granulation; drying, sieving and lubrication of granules. -Coated tablets: types, industrial examples. Quality control of tablets prepared in the laboratory and of industrial products. Disintegration test and dissolution test. 7. Interactions occurring in pharmaceutical dosage forms -Drug interactions and ways of avoiding them. Magistral formulations containing solid industrial products. the studied topic. Laboratory-scale compression of tablets on a single-punch tablet press; the studied topic the studied topic 6 hours 6 hours 9 hours 3 hours Bibliography 1. Delivery Systems. 10th Edition. Allen LV, Ansel HC (editors). Lippincott, Williams & Wilkins, Popovici I, Lupuleasa D. Pharmaceutical Technology. Vol. III. Iasi: Polirom Publishing House, Swarbrick J, Boylan JC. Encylopedia of Pharmaceutical Technology. New York: Ed. M. Dekker Inc., vol. I-IV, ***The Romanian Pharmacopoeia. 10 th Edition and Supplements Bucharest: Medical
6 Publishing House. 9. The agreement between the course contents and the expectations of the representatives of the epistemic communities, professional associations and employers in the field related to the program - Implementing the practical notions in the pharmaceutical compounding activity; - Correlating the theoretical notions with the specific requirements of industrial manufacturing of dosage forms. 10. Assessment Activity Assessment criteria Assessment methods Percentage of the final grade Course Knowledge of the notions Final exam at the end of 50% taught in course the semester; Seminar / Practical Activity of the student Written tests, oral 15% lessons during the semester assessment; Knowledge of the practical notions taught during the lab classes; Final practical exam; 35% Minimal standard of proficiency Promoting the exam with a minimum grade of 5 (on a scale of 1 to 10). Date: Signature of Coordinator for Teaching Activities Prof. Ilena Cojocaru, PhD Assoc. Prof. Gratiela Popa, PhD Lecturer Carmen Gafitanu, PhD Date of indorsement in the Council of the Department Signature of The Department Director Prof. Anca Miron, PhD
KING KHALID UNIVERSITY
KING KHALID UNIVERSITY COLLEGE OF PHARMACY DEPARTMENT OF PHARMACEUTICS COURSE SCHEDULE MALE SECTION SOLID DOSAGE FORMS FOR PHARMACEUTICAL SCIENCES/CLINICAL PHARMACY BY PROF DR MOHAMED FATHY Academic Session
More informationDISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION
Universitatea de Medicină şi Farmacie Grigore T. Popa Iaşi Comisia pentru asigurarea calităţii DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION 1. Information about the program UNIVERSITY: GRIGORE T. POPA
More informationREVISION OF MONOGRAPH ON TABLETS. Tablets
March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical
More informationEasy, fast and reliable!
Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. Tailormade formulated. s film coating products are one-step coating
More informationEasy, fast and reliable!
Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. s film coating products are one-step coating systems for pharmaceutical
More informationFactors responsible for the impaired bioavailability and instability rifampicin FDC
Table of contents 1.0 Introduction 1.1 Oral multiparticulate drug delivery system...2 1.2 Methods of preparing pellets...3 1.3 Extrusion-spheronization...3 1.4 Theory of pellet formation and growth...4
More informationDrug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand
Drug Development by Government Pharmaceutical Organization Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand 20August 2012 GPO s Profile GPO was established in 1966.
More informationBiopharmaceutics Dosage form factors influencing bioavailability Lec:5
Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019
More informationTechnical brochure StarLac
T R TABLETING AC DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is
More informationOCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100
IC OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE AC Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture
More informationApplication of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products
57. Starch Convention, Detmold, April 26-28, 2006 K.-J. Steffens Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products Starches, Pharmaceutical Applications _ Starches
More informationLubriTose Mannitol Michael Crowley, Director of R&D, Excipients
LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2
More informationVIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies
VIVAPHARM PVP/VA Copovidone, Ph.Eur. USP/NF, JPE, E 1208, FCC The Ultimate Tablet Binder for All Processing Technologies Direct Compression Dry Granulation Hot Melt Extrusion Wet Granulation VIVAPHARM
More informationFormulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.
Available online on www.ijcpr.com International Journal of Current Pharmaceutical Review and Research, 3(4), 105-109 Research Article ISSN: 0976-822X Formulation and Evaluation of Gastroretentive Dosage
More informationFORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group
FORMULATION CHOICE How and why they are chosen Dr Andy Fowles On behalf of ECPA Specification Expert Group Topics Why formulate? How to identify formulation options Drivers Principle formulation type overview
More informationREGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore
1 REGULATORY PERSPECTIVE Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore Contents 2 1. Role of Dissolution Testing in Generic Drug Approval 2. Dissolution Testing Recommendation for Solid Oral
More informationThe unlocked synergy of DFE Pharma MCC
The unlocked synergy of DFE Pharma MCC We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation formulations.
More informationFORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels
Seite 1 von 8 Share this story: Issue: April 2015, Posted Date: 3/30/2015 FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels INTRODUCTION Soft gelatin capsules (softgels) continue
More informationPHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION
PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION 1 PHARMACEUTICS Pharmaceutics is the science of dosage form design. The general area of study concerned with the formulation, manufacture, stability, and
More informationAUSTRALIAN MADE CAMPAIGN LIMITED
AUSTRALIAN MADE CAMPAIGN LIMITED PHARMACEUTICALS AND COMPLEMENTARY HEALTHCARE PRODUCTS - COMPLIANCE POLICY May 2018 Summary Made Campaign Limited (AMCL) is the t-for-profit organisation which administers
More informationFood supplement manufacture
Food supplement manufacture Nick Bennett BSc. RNutr April 2018 1 Introduction There are many different product formats available Liquids, powders, tablets, capsules etc Many different types of machine
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF MODIFIED REALEASE CAPSULES OF BUDESONIDE 1 K.Veera Kumari*, 2 Dr. Appa Rao, 3 Dr.Shaik.Harun
More informationPrincipals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy
Principals and Dosage Forms in the Therapy Modified Drug Release Institute of Pharmaceutical Technology and Biopharmacy Dosage forms Definition: Dosage forms are the means by which drug molecules are delivered
More informationFormulation and Development of Sustained Release Tablets of Valsartan Sodium
INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of
More informationSTARCH Application Data
STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone
More informationDesign and development of fast Melting Tablets of Terbutaline Sulphate
Design and development of fast Melting Tablets of Terbutaline Sulphate Mathew T and Agrawal S Swami Vivekanand College of Pharmacy, Khandwa Road, Indore (MP), INDIA Available online at: www.isca.in (Received
More informationSUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING
SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING Dr. Dieter Lubda MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany Agenda: Sustained release
More informationSTARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant
EXCIPIENTS STARCH 1500 Proven and Trusted Excipient for Performance and Versatility Effective and economical disintegrant Excellent stability for moisture sensitive drugs Manufactured exclusively for the
More informationUniversity of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester
University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester 5/21/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 1 Outlines Why rectal or vaginal route? Suppository
More informationLeader in custom manufacturing. for the pharmaceutical and nutraceutical industries.
Leader in custom manufacturing for the pharmaceutical and nutraceutical industries. Since its inception in April 1994, Viva Pharmaceutical Inc. has built a reputation as a leading manufacturer committed
More informationLIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)
November 2007 LIQUID PREPARATIONS FOR ORAL USE Final text for addition to The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications
More informationContract Manufacturing Fluid Bed Technology. Drying. Spray granulation. Coating. Agglomeration. Instantization.
Contract Manufacturing Fluid Bed Technology Drying. Spray granulation. Coating. Agglomeration. Instantization. Multifunctional fluid bed processor State-of-the-art fluid bed technology for a diversity
More informationFormulation and evaluation of oro-dispersible tablets of lafutidine
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationTablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good
TABLET PRODUCTİON Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good quality at high standards. Based on preformulation
More informationThe binding performance of DFE Pharma Starch
The binding performance of DFE Pharma Starch MCC Starch Lactose Inhalation Superdisintegrants We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients
More informationDESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN
Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI
More informationCo-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009
Co-Processed Excipients: Regulatory Challenges Carl Mroz Colorcon Limited June 2009 What is a Co-Processed excipient? Several types of excipient contain multiple components by design Use of processing
More informationPharmaceutical Preparation For Internal Use
Pharmaceutical Preparation For Internal Use 1. Solid Preparations (Tablet, Capsule, Pill) 2. Liquid Preparations (Aqua, Syrup, Elixir, Extract, Liquor, Emulsion, Mixture, Infusion, Decoction). 3. Powder
More informationChallenges and solutions for moisture sensitive API formulation
Challenges and solutions for moisture sensitive API formulation Introduction Today, formulators are looking for alternative processes to reformulate existing products or to formulate New Chemical Entities
More informationPHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY
PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY Excipients are inactive ingredients used as carriers for the active ingredients in a pharmaceutical product. These may
More informationCHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION
CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION LEARNING OBJECTIVES The objectives of this unit are to: Understand the formulation of solid dosage form. Understand the characteristic
More informationCommercial Bulleting Aloe Flakes
Commercial Bulleting Aloe Flakes Be a Pioneer using Aloe Vera Flakes in food and beverage industry AMB s exclusive Aloe Flakes demonstrates superior solubility retaining the highest percentage of the benefical
More informationEUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL VOLUME 2C. Guidelines. Medicinal products for human use
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Brussels, March 2018 SANTE-2017-11668 Revision 2 NOTICE TO APPLICANTS VOLUME 2C Guidelines Medicinal products for human use Safety, environment
More informationIngredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose
1 Pharmaceutical industry borrowed ingredients from other industries Food Cosmetic Industrial Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work that has all changed
More informationINFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationFLAVOUR FLOW & ADHESION
FLAVOUR FLOW & ADHESION Nicole Bruyndonckx GRIFFITH FOODS Dry Seasonings Global manufacturer of savoury food ingredients since 1919 Sauces & Marinades Canada USA Mexico Costa Rica Colombia United Kingdom
More informationLAB.2. Tablet Production Methods
LAB.2 Tablet Production Methods Dry methods Direct compression Dry granulation Wet methods Wet granulation Regardless whether tablets are made by direct compression or granulation, the first step, milling
More informationDESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG M Seth *, DS Goswami,
More informationExcipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015
Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of
More informationTechnical brochure CombiLac
OM I AC TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is
More informationFormulation and evaluation of sublingual tablets of lisinopril
Journal of GROVER Scientific & Industrial AGARWAL: Research FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF LISINOPRIL Vol. 71, June 2012, pp. 413-417 413 Formulation and evaluation of sublingual tablets
More informationInternational Journal of PharmTech Research
International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 0974-4304 Vol.8, No.3, pp 371-376, 2015 Application of Cow Ghee as an excipient in Hot Melt Coating agent in controlled release rifampicin
More informationFORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN
FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN Ms. Jyoti Rathore 1*, Mr. Hitesh Kumar Parmar 1 Ujjain Institute of Pharmaceutical Sciences, Ujjain. Email- hkparmar7@rediffmail.com ABSTRACT
More informationAvailable online through
Research Article Available online through www.ijrap.net DESIGN AND EVALUATION OF LOW COST DIRECTLY COMPRESSIBLE EXCIPIENTS Swamy P. V. *, Patil A. N., Shirsand S. B., Amitkumar T., Laeeq Farhana H.K.E
More informationAvailable online Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 26, 8(2):7-7 Research Article ISSN : 975-7384 CODEN(USA) : JCPRC5 Optimization of directly compressible mixtures of microcrystalline
More informationPaper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives
Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives 2.1 Introduction According to the Food Protection Committee of the Food and Nutrition Board, food additives
More informationFormulation and evaluation of immediate release salbutamol sulphate
5 Formulation, optimization and evaluation of immediate release layer of salbutamol sulphate Salbutamol is moderately selective beta (2)-receptor agonist similar in structure to terbutaline and widely
More informationUSP Chewable Gels Monographs
USP Dietary Supplements Stakeholder Forum Tuesday, May 15, 2018 USP Chewable Gels Monographs Natalia Davydova, Ph.D. Scientific Liaison DS Gummies Market Value of the gummy vitamins market in the United
More informationOPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
Digest Journal of Nanomaterials and Biostructures Vol. 9, No. 3, July September 2014, p. 1077-1084 OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
More informationSENTRY TM POLYOX Water Soluble Resins
SENTRY TM POLYOX Water Soluble Resins Technical Information on Stability Introduction Key Points Antioxidants SENTRY POLYOX WSR resins consist of a family of high molecular weight polyethers with nominal
More informationAMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES
AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES Page Current text Revised text Notes P.21 A. 10.1. WHO classification
More informationPharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency
Pharma & Food Solutions POLYOX TM Water Soluble Resins Combining Flexibility with Consistency POLYOX 9-13 POLYOX 9-13 POLYOX * are nonionic poly (ethylene oxide) polymers that meet all the specifications
More informationFAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS SULPHUR. FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1973
AGP: CP/58 FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS SULPHUR FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1973 DISCLAIMER 1 FAO specifications are developed with the basic objective
More informationCONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications
Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information
More informationDecentralised Procedure. Public Assessment Report
Decentralised Procedure Public Assessment Report Venlafaxin ratiopharm Venlafaxin AbZ-Pharma Venlafaxin CT-Arzneimittel prolonged-release capsule hard venlafaxine hydrochloride DE/H/3393-3395/01-03/DC
More informationInnovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017
Innovations in Design: NIA-West Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 1 Innovations in Design: How Do You Stand Out? If all other competitors are the same
More informationCOPYRIGHTED MATERIAL. Contents. xiv xv xvi. About the authors Preface Acknowledgments
About the authors Preface Acknowledgments 1 Introduction to spray drying 1 1.1 Introduction 1 1.2 Stage 1: Atomization 2 1.2.1 Principle of atomization 3 1.2.2 Classification of atomizers 4 1.2.2.1 Rotary
More informationDirect Compression. With the right ingredients it s a simple, cost-effective manufacturing process
Direct With the right ingredients it s a simple, cost-effective manufacturing process TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Speed and savings sounds good to us
More information(12) Patent Application Publication (10) Pub. No.: US 2003/ A1
US 2003.01.18647A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0118647 A1 Seth (43) Pub. Date: (54) EXTENDED RELEASE TABLET OF Publication Classification METFORMIN (51)
More informationGranulation Aggregation
Granulation Aggregation Wet granulation Solvent granulation (crust granules) Binder granulation (sticked granules) Granulation liquid Water Water + alcohol mixture Macromolecular colloidal solution i.e.:
More information905 UNIFORMITY OF DOSAGE UNITS
Change to read: 905 UNIFORMITY OF DOSAGE UNITS [ NOTE In this chapter, unit and dosage unit are synonymous. ] To ensure the consistency of dosage units, each unit in a batch should have a drug substance
More informationCritical material properties for the design of robust drug products : excipient functionality related characteristics
Critical material properties for the design of robust drug products : excipient functionality related characteristics Dr Liz Meehan, Pharmaceutical Development, Macclesfield UK 1 Excipients Definition
More informationAsian Journal of Biochemical and Pharmaceutical Research
ISSN: 2231-2560 Research Article Asian Journal of Biochemical and Pharmaceutical Research Design and Evaluation of Gastroretentive Floating Tablets of Dipyridamole: Influence of Formulation Variables A.
More informationANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.
2. EXCIPIENTS PROFILES ANNEXURE -2 Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2.1. COMPRITOL 888 Non proprietary names BP:
More informationGeneral Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe
General Concepts in the European Pharmacopoeia Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General notices Anne-Sophie Bouin, 28/10/09 2009 EDQM, Council of Europe, All
More informationDesign and In-vitro Evaluation of Silymarin Bilayer Tablets
CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin
More informationKolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.
Technical Information Kolliwax HCO September 2015 03_150617e_00/Page 1 of 8 WF-No. 129938 = Registered trademark in many countries Hydrogenated castor oil powder for pharmaceutical use 03_150617e_00 September
More informationThe influence of lactose particle size on dry powder inhalation performance
The influence of lactose particle size on dry powder inhalation performance MCC Starch Lactose Inhalation Superdisintegrants 1 Introduction In most dry powder inhalation (DPI) formulations carriers are
More informationTABLET DESIGN AND FORMULATION
TABLET DESIGN AND FORMULATION PART 5 Industrial pharmacy 5th class 1st semester TABLET DESIGN AND FORMULATION Conventional oral tablets for ingestion usually contain the same classes of components in addition
More informationAddendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT
Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT Introductory Note: The revised model specifications for tablets (ST, WT, DT) have been jointly
More informationShort Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.
61 East and Central African Journal of Pharmaceutical Sciences Vol. 18 (2015) 61-66 Short Communication Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L.
More informationIJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article PREPARATION, CHARACTERIZATION AND EVALUATION OF PGS - PVP CO-PROCESSED EXCIPIENT AS DIRECTLY
More informationNon-Food Uses of Polysaccharides
Non-Food Uses of Polysaccharides John Mitchell John.Mitchell@biopolymersolutions.co.uk Acknowledgements Fundamentals of Hydrocolloid Technology Course (2003-2009) Rob Winwood Colin Melia Steve Harding
More informationA. General Appearance
TABLET EVALUATION To design tablets and later monitor tablet production quality, quantitative evaluations and assessments of a tablet s chemical, physical, and bioavailability properties must be made.
More informationFormulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch
Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,
More informationInt. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION
More information7. SUMMARY, CONCLUSION AND RECOMMENDATIONS
211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability
More informationFormulation Development and Evaluation of Bilayer Floating Tablet of Antidiabetic Drugs
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 0, 8 ():- (http://scholarsresearchlibrary.com/archive.html) ISSN 097-07 USA CODEN: DPLEB Formulation
More informationExcipient Considerations for Continuous Manufacturing Implementation
Excipient Considerations for Continuous Manufacturing Implementation FDA-PQRI Conference March 22-24, 2017 David R. Schoneker Director of Global Regulatory Affairs Email: dschoneker@colorcon.com 1 Continuous
More informationJournal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Studies on Carica Papaya Starch as a Pharmaceutical Excipient
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(6):3134-3138 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Studies on Carica Papaya Starch as a Pharmaceutical
More informationCompletion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation
Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation Workshop on Paediatric Formulations For Assessors in National Regulatory Agencies
More information372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014
372 J App Pharm Vol. 6; Issue 4: 372-379; October, 2014 Moazzem et al, 2014 Original Research Article EFFECT OF SUPERDISINTEGRATING AGENT ON THE RELEASE OF METFORMIN HCl FROM IMMEDIATE RELEASE TABLETS
More informationSTABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS
Int. J. Chem. Sci.: 8(1), 2010, 405-414 STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS V. L. NARASAIAH, T. KARTHIK KUMAR, D. SRINIVAS, K. SOWMYA, P. L. PRAVALLIKA and Sk. Md. MOBEEN
More informationINFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationFLORITER. New Technology for Innovative Formulation Design.
FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent
More informationWhy and how does a pharmaceutical company take the risk to use novel excipients?
Why and how does a pharmaceutical company take the risk to use novel excipients? M. Sherry Ku, Ph.D. CSO, Anchen Pharmaceuticals Irvine, CA Excipient Fest, May 5, 2010 Puerto Rico Global Excipient Acceptability
More informationEP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39
(19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 233 131 A1 (43) Date of publication: 29.09. Bulletin /39 (1) Int Cl.: A61K 9/ (06.01) A61K 31/00 (06.01) (21) Application number: 09908.8 (22) Date of filing:
More informationSenior Scientist / Principal Scientist. Compounding Manager (Sterile and non-sterile specials) Senior Pharmaceutical Assessor
Curriculum Vitae PERSONAL INFORMATION Andrew Twitchell WORK EXPERIENCE May 1987 September 1991 Senior Scientist / Principal Scientist 3M Health Care Ltd, (United Kingdom) Formulation, scale-up and manufacture
More informationCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
A23G COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF Confectionery products, chocolate, cocoa products, chewing
More informationFormulation and Evaluation of Glicazide Mouth Dissolving Tablets
Research Article Vishakha S. Hastak*, Yogyata S. Pathare, Kiran C. Mahajan Department of Pharmaceutics, Shree Chanakya Education Society's Indira college of Pharmacy, Tathawade, Pune, Maharashtra, India.
More information